Clicky

Cytokinetics, Incorporated(CYTK) News

Date Title
May 8 Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586
May 8 Insider Sale at Cytokinetics Inc (CYTK): EVP Research & Development Fady Malik Sells Shares
May 7 Cytokinetics to Hold Annual Meeting of Stockholders
May 1 Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Apr 29 Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
Apr 24 Cytokinetics to Announce First Quarter Results on May 8, 2024
Apr 10 This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
Apr 10 Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
Apr 9 EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)
Apr 5 Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session
Apr 1 Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Mar 25 Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session
Mar 20 2 Incredible Growth Stocks to Buy Right Now
Mar 17 30 Biggest Biotechnology Companies in the World
Mar 13 7 Biotech Stocks to Buy as Sector Rotation Ramps Up
Mar 12 Q4 2023 CytomX Therapeutics Inc Earnings Call
Mar 4 Cytokinetics to Participate in March Investor Conferences
Jan 12 Today’s Stock Market Movers: JPMorgan, Bank of America, Citigroup, Delta, United, UnitedHealth, Tesla, and More
Jan 12 Cytokinetics (CYTK) Down on Report of Novartis Not Interested
Jan 11 Novartis Retreats From Cytokinetics Deal, Dashing Hopes For Multi-Billion Dollar Acquisition